share_log

NexImmune | 4: Statement of changes in beneficial ownership of securities-Officer Jones Kristi

SEC ·  Jun 14 07:59

Summary by Futu AI

NexImmune, Inc. President and CEO, Kristi Jones, completed a purchase of the company's stock on June 11, 2024. The transaction involved the acquisition of 1 share of NexImmune's Series A Preferred Stock at a price of $0.01 per share. Following the transaction, Jones holds a total of 1 share in direct ownership. The transaction reflects the executive's confidence in the company and provides investors with a signal of potential future performance.
NexImmune, Inc. President and CEO, Kristi Jones, completed a purchase of the company's stock on June 11, 2024. The transaction involved the acquisition of 1 share of NexImmune's Series A Preferred Stock at a price of $0.01 per share. Following the transaction, Jones holds a total of 1 share in direct ownership. The transaction reflects the executive's confidence in the company and provides investors with a signal of potential future performance.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.